Fleurie Investments

Fleurie Investments is a private investment vehicle and holding company that operates as part of the Waypoint Group, the business enterprise for the Bertarelli family. The firm is primarily focused on the life sciences and healthcare sectors, where it identifies and manages strategic long-term investments. Its most significant holding is Stallergenes Greer, a global leader in the development and commercialization of allergy immunotherapy products. Fleurie Investments provides capital and strategic oversight to support the growth and clinical development programs of its portfolio companies, leveraging the deep industry expertise of the Waypoint Group.